Aspen Pharmacare delivers first batch of J&J COVID-19 vaccine

SOUTH AFRICA – South Africa’s Aspen Pharmacare will supply the first batch of Johnson & Johnson COVID-19 vaccine to the country as from today, the drug maker has announced. These will be the first set of vaccines to be manufactured in the country from active pharmaceutical ingredients (API), substances used to make the final drug product, sourced from Europe. “Supply for Africa and South Africa is particularly rewarding, given the current global inequality in accessing vaccines,” Stephen Saad, chief executive of Aspen said in a statement. “This represents a big…

Read More

Aspen secures ZAR 10 billion to bolster operations amid Covid-19 vaccine drive

SOUTH AFRICA – Aspen Pharmacare has secured a US$ 698 million (SAR10 billion) financing package to support the pharmaceutical firm’s operations, including the production of vaccines. The United States International Development Finance Corporation (DFC) in collaboration with the World Bank Group, Germany, and France announced a joint investment to boost vaccine manufacturing capacity in Africa. This is the largest healthcare investment and mobilization the IFC has led globally to date. The financing will help Aspen to refinance existing debt and strengthen the company’s balance sheet, supporting Aspen’s operations, including production…

Read More

Liseko investment denies having any ties to Aspen Pharmacare

SOUTH AFRICA – Liseko Investments, a small 17-year-old passive investment holding company owned by a group of medical doctors, has distanced itself from claims alleging the company is a partner to Aspen Pharmacare. This follows claims made by Fana Mokoena, a political leader in the country, linking the investments company to the pharmaceutical giant charged with production of the J&J vaccine. Liseko is threatening to take legal action against Fana Mokoena for what it said were defamatory comments he posted on Twitter on Friday. These comments were made on the…

Read More

Aspen Pharmacare reacts to FDAs directive for a batch of Johnson & Johnson COVID-19 vaccines to be destroyed

SOUTH AFRICA – Aspen, a global multinational specialty pharmaceutical company, has sqaid in a statement released to the press that they are disappointed to learn specific batches of the Johnson & Johnson COVID-19 vaccine manufactured at  Gqeberha production site and designated for the South African market have to be destroyed due to the Good Manufacturing Practice risk of isolated material in the drug substance supplied to Aspen by Johnson & Johnson from their contract manufacturing partner in the USA, Emergent.  The batches manufactured had been retained in storage awaiting the…

Read More

IFC, Proparco, DEG and DFC to support Covid-19 vaccine and pharma manufacturing in Africa

SOUTH AFRICA – The International Finance Corporation (IFC), Proparco, the German Development Finance Institution (DEG) and the U.S. International Development Finance Corporation (DFC) have announced a partnership to support vaccine manufacturing in Africa, pharmaceutical development so as to accelerate the continent’s recovery from the COVID-19 pandemic. Through the partnership, IFC, Proparco, a subsidiary of Agence Française de Développement (AFD Group), DEG and DFC, along with other partners, are exploring potential collaboration with vaccine producers on the continent, including Aspen, among others, to support the continued development of sustainable local vaccine…

Read More